Develops minimally invasive medical devices for obesity treatment and metabolic disorders.
ReShape Lifesciences Inc. is a leading medical device company dedicated to addressing obesity and metabolic diseases across global markets including the United States, Australia, and Europe. The company's diverse product portfolio includes the Lap-Band System, renowned for its minimally invasive approach to long-term treatment of severe obesity, offering an alternative to more invasive surgical procedures like gastric bypass or sleeve gastrectomy. Another innovative offering is the ReShape Vest system, currently undergoing investigation. This laparoscopically implanted device wraps around the stomach to facilitate weight loss in obese and morbidly obese patients without altering stomach anatomy or bypassing gastrointestinal tracts.
In addition to its pioneering devices, ReShape Lifesciences Inc. provides comprehensive support solutions such as the ReShapeCare virtual health coaching program. This telehealth platform supports patients undergoing medically managed weight loss, promoting sustainable lifestyle changes and healthy habits. The company also engages in advanced research with initiatives like the ReShape Diabetes Bloc-Stim Neuromodulation, a promising technology in preclinical development for treating type 2 diabetes mellitus.
Established in 2002 and headquartered in San Clemente, California, ReShape Lifesciences Inc. was originally known as EnteroMedics Inc. before rebranding in 2017. With a commitment to innovation and patient-centric solutions, the company continues to pioneer advancements in medical devices aimed at improving outcomes and quality of life for individuals affected by obesity and related metabolic conditions worldwide.